Innospec (NASDAQ:IOSP – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday.
Innospec Stock Up 0.4 %
NASDAQ:IOSP opened at $104.01 on Wednesday. The company has a market cap of $2.60 billion, a PE ratio of 73.25 and a beta of 1.09. The business’s 50 day moving average is $110.29 and its two-hundred day moving average is $112.31. Innospec has a 52 week low of $99.49 and a 52 week high of $133.71.
Innospec (NASDAQ:IOSP – Get Free Report) last announced its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.05. The firm had revenue of $466.80 million for the quarter, compared to analysts’ expectations of $447.43 million. Innospec had a return on equity of 12.27% and a net margin of 1.93%. As a group, sell-side analysts expect that Innospec will post 6.18 EPS for the current fiscal year.
Insider Activity
Institutional Investors Weigh In On Innospec
A number of hedge funds have recently added to or reduced their stakes in the stock. Wasatch Advisors LP increased its holdings in shares of Innospec by 0.6% in the 3rd quarter. Wasatch Advisors LP now owns 1,805,546 shares of the specialty chemicals company’s stock worth $204,189,000 after acquiring an additional 11,231 shares during the period. State Street Corp grew its position in Innospec by 2.1% in the 3rd quarter. State Street Corp now owns 996,281 shares of the specialty chemicals company’s stock worth $112,669,000 after purchasing an additional 20,744 shares during the last quarter. Victory Capital Management Inc. increased its stake in shares of Innospec by 1.6% in the fourth quarter. Victory Capital Management Inc. now owns 922,220 shares of the specialty chemicals company’s stock valued at $101,500,000 after purchasing an additional 14,188 shares during the period. Royce & Associates LP increased its stake in shares of Innospec by 9.3% in the third quarter. Royce & Associates LP now owns 835,333 shares of the specialty chemicals company’s stock valued at $94,468,000 after purchasing an additional 70,902 shares during the period. Finally, Geode Capital Management LLC raised its holdings in shares of Innospec by 2.2% during the fourth quarter. Geode Capital Management LLC now owns 692,071 shares of the specialty chemicals company’s stock valued at $76,184,000 after buying an additional 14,788 shares during the last quarter. 96.64% of the stock is currently owned by institutional investors.
About Innospec
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Recommended Stories
- Five stocks we like better than Innospec
- 3 Dividend Kings To Consider
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- What Are Growth Stocks and Investing in Them
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- 3 REITs to Buy and Hold for the Long Term
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.